+1 |BT| (ROOT (NP (NP (JJ Severe) (JJ immune) (JJ hemolytic) (NN anemia)) (VP (VBN associated) (PP (IN with) (NP (NP (NN prophylactic) (NN use)) (PP (IN of) (NP (NN cefotetan))))) (PP (IN in) (NP (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)) (: ;) (S (S (ADVP (LS Second)) (PRN (: -) (CC and) (S (NP (NP (JJ third-generation) (NNS cephalosporins)) (, ,) (NP (RB especially) (NN cefotetan)) (, ,)) (VP (VBP are) (ADVP (RB increasingly)) (VP (VBN associated) (PP (IN with) (NP (ADJP (JJ severe) (, ,) (RB sometimes) (JJ fatal)) (JJ immune) (JJ hemolytic) (NN anemia)))))) (: ;)) (NP (PRP We)) (VP (VBD noticed) (SBAR (IN that) (S (NP (NP (CD 10)) (PP (IN of) (NP (NP (PRP$ our) (CD 35) (NNS cases)) (PP (IN of) (NP (JJ cefotetan-induced) (JJ hemolytic) (NNS anemias)))))) (VP (VBD were) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NN cefotetan)) (ADVP (RB prophylactically)) (PP (IN for) (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)))))))))))))) (: ;) (S (NP (NP (CD Eight)) (PP (IN of) (NP (NP (DT these) (NNS cases)) (PP (IN of) (NP (JJ severe) (JJ immune) (JJ hemolytic) (NN anemia)))))) (VP (VBP are) (VP (VBN described)))))))) (: ;))) |ET| |BV| 1:0.014705540612339973 2:0.017108092084527016 3:0.012121366336941719 4:0.020705288276076317 5:-0.018062273040413857 6:-0.0042962627485394478 7:0.016012204810976982 8:0.010152262635529041 9:0.015407168306410313 10:0.0042153783142566681 11:-0.012496859766542912 12:0.012068960815668106 13:-0.000694024667609483 14:0.013049256056547165 15:0.022173577919602394 16:-0.00051119003910571337 17:-0.0079763196408748627 18:-0.012158798985183239 19:-0.019536826759576797 20:0.020064596086740494 21:0.001632781233638525 22:0.005636784655507654 23:-0.018426516093313694 24:0.014691048767417669 25:-0.010155509429750964 26:0.00090009137056767941 27:-0.015275134705007076 28:0.011743893381208181 29:0.0024022478610277176 30:-0.012549271108582616 31:-0.020526587963104248 32:0.0025704629952087998 33:0.007655004970729351 34:0.0078446818515658379 35:-0.011334342183545232 36:0.010796420508995652 37:0.011697327252477407 38:-0.0066223684698343277 39:-0.0053259092383086681 40:0.019183248281478882  |EV|
+1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.015284553170204163 2:0.012397637590765953 3:0.019799297675490379 4:0.0086963791400194168 5:0.0076053692027926445 6:-0.022937361150979996 7:-0.0037403455935418606 8:-0.021618017926812172 9:-0.0049511343240737915 10:0.01359514519572258 11:0.022477952763438225 12:0.0071526519022881985 13:0.0075015067122876644 14:0.0016949253622442484 15:0.012849573977291584 16:0.018865300342440605 17:0.0018628699472174048 18:-0.010762708261609077 19:-0.016511915251612663 20:-0.010297090746462345 21:0.014591557517026862 22:0.013617152192940315 23:0.011663846399945518 24:0.0055554577459891634 25:-0.007820756485064825 26:-0.016835317015647888 27:0.0030276738107204437 28:0.00069436283471683658 29:-0.0046331050495306654 30:-0.0036702662085493407 31:-0.0017336808377876878 32:0.0036024406241873899 33:-0.0027646061886722841 34:0.0069731992358962698 35:-0.01508762159695228 36:0.01198609204341968 37:0.0017028081541260083 38:0.00075433465341726935 39:-0.0063108938435713453 40:-0.012405697023496032  |EV|
-1 |BT| (ROOT (NP (NP (JJ Severe) (JJ immune) (JJ hemolytic) (NN anemia)) (VP (VBN associated) (PP (IN with) (NP (NP (NN prophylactic) (NN use)) (PP (IN of) (NP (NN cefotetan))))) (PP (IN in) (NP (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)) (: ;) (S (S (ADVP (LS Second)) (PRN (: -) (CC and) (S (NP (NP (JJ third-generation) (NNS cephalosporins)) (, ,) (NP (RB especially) (NN cefotetan)) (, ,)) (VP (VBP are) (ADVP (RB increasingly)) (VP (VBN associated) (PP (IN with) (NP (ADJP (JJ severe) (, ,) (RB sometimes) (JJ fatal)) (JJ immune) (JJ hemolytic) (NN anemia)))))) (: ;)) (NP (PRP We)) (VP (VBD noticed) (SBAR (IN that) (S (NP (NP (CD 10)) (PP (IN of) (NP (NP (PRP$ our) (CD 35) (NNS cases)) (PP (IN of) (NP (JJ cefotetan-induced) (JJ hemolytic) (NNS anemias)))))) (VP (VBD were) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NN cefotetan)) (ADVP (RB prophylactically)) (PP (IN for) (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)))))))))))))) (: ;) (S (NP (NP (CD Eight)) (PP (IN of) (NP (NP (DT these) (NNS cases)) (PP (IN of) (NP (JJ severe) (JJ immune) (JJ hemolytic) (NN anemia)))))) (VP (VBP are) (VP (VBN described)))))))) (: ;))) |ET| |BV| 1:-0.0051091229543089867 2:0.0011301975464448333 3:0.017879225313663483 4:-0.0092233959585428238 5:0.0041576828807592392 6:0.013764913193881512 7:-0.017415830865502357 8:-0.014374793507158756 9:-0.011487646028399467 10:0.0002230519603472203 11:-0.0073853987269103527 12:0.015321903862059116 13:0.004775182344019413 14:-0.0066833538003265858 15:0.022043006494641304 16:0.0057606999762356281 17:0.0031788034830242395 18:-0.0045014782808721066 19:-0.012975300662219524 20:0.019693996757268906 21:0.001632781233638525 22:0.005636784655507654 23:-0.018426516093313694 24:0.014691048767417669 25:-0.010155509429750964 26:0.00090009137056767941 27:-0.015275134705007076 28:0.011743893381208181 29:0.0024022478610277176 30:-0.012549271108582616 31:-0.020526587963104248 32:0.0025704629952087998 33:0.007655004970729351 34:0.0078446818515658379 35:-0.011334342183545232 36:0.010796420508995652 37:0.011697327252477407 38:-0.0066223684698343277 39:-0.0053259092383086681 40:0.019183248281478882  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:-0.0051091229543089867 2:0.0011301975464448333 3:0.017879225313663483 4:-0.0092233959585428238 5:0.0041576828807592392 6:0.013764913193881512 7:-0.017415830865502357 8:-0.014374793507158756 9:-0.011487646028399467 10:0.0002230519603472203 11:-0.0073853987269103527 12:0.015321903862059116 13:0.004775182344019413 14:-0.0066833538003265858 15:0.022043006494641304 16:0.0057606999762356281 17:0.0031788034830242395 18:-0.0045014782808721066 19:-0.012975300662219524 20:0.019693996757268906 21:-0.0073787732981145382 22:0.005766372662037611 23:-0.0046739033423364162 24:-0.000444008968770504 25:-0.0002641468308866024 26:-0.0036098407581448555 27:-0.0094042459968477488 28:-0.016590696759521961 29:0.010893914848566055 30:-0.013082699384540319 31:0.0031072222627699375 32:0.0044354451820254326 33:-0.0019872291013598442 34:0.0052262714598327875 35:-0.0018099537119269371 36:-0.0095137287862598896 37:-0.0070116393035277724 38:-0.010731657966971397 39:-0.0017925328575074673 40:-0.00077439937740564346  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:-0.0051091229543089867 2:0.0011301975464448333 3:0.017879225313663483 4:-0.0092233959585428238 5:0.0041576828807592392 6:0.013764913193881512 7:-0.017415830865502357 8:-0.014374793507158756 9:-0.011487646028399467 10:0.0002230519603472203 11:-0.0073853987269103527 12:0.015321903862059116 13:0.004775182344019413 14:-0.0066833538003265858 15:0.022043006494641304 16:0.0057606999762356281 17:0.0031788034830242395 18:-0.0045014782808721066 19:-0.012975300662219524 20:0.019693996757268906 21:0.001632781233638525 22:0.005636784655507654 23:-0.018426516093313694 24:0.014691048767417669 25:-0.010155509429750964 26:0.00090009137056767941 27:-0.015275134705007076 28:0.011743893381208181 29:0.0024022478610277176 30:-0.012549271108582616 31:-0.020526587963104248 32:0.0025704629952087998 33:0.007655004970729351 34:0.0078446818515658379 35:-0.011334342183545232 36:0.010796420508995652 37:0.011697327252477407 38:-0.0066223684698343277 39:-0.0053259092383086681 40:0.019183248281478882  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:-0.0051091229543089867 2:0.0011301975464448333 3:0.017879225313663483 4:-0.0092233959585428238 5:0.0041576828807592392 6:0.013764913193881512 7:-0.017415830865502357 8:-0.014374793507158756 9:-0.011487646028399467 10:0.0002230519603472203 11:-0.0073853987269103527 12:0.015321903862059116 13:0.004775182344019413 14:-0.0066833538003265858 15:0.022043006494641304 16:0.0057606999762356281 17:0.0031788034830242395 18:-0.0045014782808721066 19:-0.012975300662219524 20:0.019693996757268906 21:0.014046891592442989 22:-0.022031821310520172 23:0.014686155132949352 24:0.011038403026759624 25:-0.018630057573318481 26:-0.020363522693514824 27:-0.022811960428953171 28:0.0012653849553316832 29:0.0022130496799945831 30:0.0035870547872036695 31:0.0065613710321485996 32:0.024283336475491524 33:-0.022283038124442101 34:-0.00083428749348968267 35:0.016746236011385918 36:0.00077113014413043857 37:0.020174669101834297 38:5.3726835176348686e-05 39:0.017781134694814682 40:0.0095463357865810394  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:-0.0051091229543089867 2:0.0011301975464448333 3:0.017879225313663483 4:-0.0092233959585428238 5:0.0041576828807592392 6:0.013764913193881512 7:-0.017415830865502357 8:-0.014374793507158756 9:-0.011487646028399467 10:0.0002230519603472203 11:-0.0073853987269103527 12:0.015321903862059116 13:0.004775182344019413 14:-0.0066833538003265858 15:0.022043006494641304 16:0.0057606999762356281 17:0.0031788034830242395 18:-0.0045014782808721066 19:-0.012975300662219524 20:0.019693996757268906 21:0.014591557517026862 22:0.013617152192940315 23:0.011663846399945518 24:0.0055554577459891634 25:-0.007820756485064825 26:-0.016835317015647888 27:0.0030276738107204437 28:0.00069436283471683658 29:-0.0046331050495306654 30:-0.0036702662085493407 31:-0.0017336808377876878 32:0.0036024406241873899 33:-0.0027646061886722841 34:0.0069731992358962698 35:-0.01508762159695228 36:0.01198609204341968 37:0.0017028081541260083 38:0.00075433465341726935 39:-0.0063108938435713453 40:-0.012405697023496032  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.015284553170204163 2:0.012397637590765953 3:0.019799297675490379 4:0.0086963791400194168 5:0.0076053692027926445 6:-0.022937361150979996 7:-0.0037403455935418606 8:-0.021618017926812172 9:-0.0049511343240737915 10:0.01359514519572258 11:0.022477952763438225 12:0.0071526519022881985 13:0.0075015067122876644 14:0.0016949253622442484 15:0.012849573977291584 16:0.018865300342440605 17:0.0018628699472174048 18:-0.010762708261609077 19:-0.016511915251612663 20:-0.010297090746462345 21:-0.0073787732981145382 22:0.005766372662037611 23:-0.0046739033423364162 24:-0.000444008968770504 25:-0.0002641468308866024 26:-0.0036098407581448555 27:-0.0094042459968477488 28:-0.016590696759521961 29:0.010893914848566055 30:-0.013082699384540319 31:0.0031072222627699375 32:0.0044354451820254326 33:-0.0019872291013598442 34:0.0052262714598327875 35:-0.0018099537119269371 36:-0.0095137287862598896 37:-0.0070116393035277724 38:-0.010731657966971397 39:-0.0017925328575074673 40:-0.00077439937740564346  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.015284553170204163 2:0.012397637590765953 3:0.019799297675490379 4:0.0086963791400194168 5:0.0076053692027926445 6:-0.022937361150979996 7:-0.0037403455935418606 8:-0.021618017926812172 9:-0.0049511343240737915 10:0.01359514519572258 11:0.022477952763438225 12:0.0071526519022881985 13:0.0075015067122876644 14:0.0016949253622442484 15:0.012849573977291584 16:0.018865300342440605 17:0.0018628699472174048 18:-0.010762708261609077 19:-0.016511915251612663 20:-0.010297090746462345 21:0.001632781233638525 22:0.005636784655507654 23:-0.018426516093313694 24:0.014691048767417669 25:-0.010155509429750964 26:0.00090009137056767941 27:-0.015275134705007076 28:0.011743893381208181 29:0.0024022478610277176 30:-0.012549271108582616 31:-0.020526587963104248 32:0.0025704629952087998 33:0.007655004970729351 34:0.0078446818515658379 35:-0.011334342183545232 36:0.010796420508995652 37:0.011697327252477407 38:-0.0066223684698343277 39:-0.0053259092383086681 40:0.019183248281478882  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.015284553170204163 2:0.012397637590765953 3:0.019799297675490379 4:0.0086963791400194168 5:0.0076053692027926445 6:-0.022937361150979996 7:-0.0037403455935418606 8:-0.021618017926812172 9:-0.0049511343240737915 10:0.01359514519572258 11:0.022477952763438225 12:0.0071526519022881985 13:0.0075015067122876644 14:0.0016949253622442484 15:0.012849573977291584 16:0.018865300342440605 17:0.0018628699472174048 18:-0.010762708261609077 19:-0.016511915251612663 20:-0.010297090746462345 21:0.014046891592442989 22:-0.022031821310520172 23:0.014686155132949352 24:0.011038403026759624 25:-0.018630057573318481 26:-0.020363522693514824 27:-0.022811960428953171 28:0.0012653849553316832 29:0.0022130496799945831 30:0.0035870547872036695 31:0.0065613710321485996 32:0.024283336475491524 33:-0.022283038124442101 34:-0.00083428749348968267 35:0.016746236011385918 36:0.00077113014413043857 37:0.020174669101834297 38:5.3726835176348686e-05 39:0.017781134694814682 40:0.0095463357865810394  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.014705540612339973 2:0.017108092084527016 3:0.012121366336941719 4:0.020705288276076317 5:-0.018062273040413857 6:-0.0042962627485394478 7:0.016012204810976982 8:0.010152262635529041 9:0.015407168306410313 10:0.0042153783142566681 11:-0.012496859766542912 12:0.012068960815668106 13:-0.000694024667609483 14:0.013049256056547165 15:0.022173577919602394 16:-0.00051119003910571337 17:-0.0079763196408748627 18:-0.012158798985183239 19:-0.019536826759576797 20:0.020064596086740494 21:-0.0073787732981145382 22:0.005766372662037611 23:-0.0046739033423364162 24:-0.000444008968770504 25:-0.0002641468308866024 26:-0.0036098407581448555 27:-0.0094042459968477488 28:-0.016590696759521961 29:0.010893914848566055 30:-0.013082699384540319 31:0.0031072222627699375 32:0.0044354451820254326 33:-0.0019872291013598442 34:0.0052262714598327875 35:-0.0018099537119269371 36:-0.0095137287862598896 37:-0.0070116393035277724 38:-0.010731657966971397 39:-0.0017925328575074673 40:-0.00077439937740564346  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.014705540612339973 2:0.017108092084527016 3:0.012121366336941719 4:0.020705288276076317 5:-0.018062273040413857 6:-0.0042962627485394478 7:0.016012204810976982 8:0.010152262635529041 9:0.015407168306410313 10:0.0042153783142566681 11:-0.012496859766542912 12:0.012068960815668106 13:-0.000694024667609483 14:0.013049256056547165 15:0.022173577919602394 16:-0.00051119003910571337 17:-0.0079763196408748627 18:-0.012158798985183239 19:-0.019536826759576797 20:0.020064596086740494 21:0.014046891592442989 22:-0.022031821310520172 23:0.014686155132949352 24:0.011038403026759624 25:-0.018630057573318481 26:-0.020363522693514824 27:-0.022811960428953171 28:0.0012653849553316832 29:0.0022130496799945831 30:0.0035870547872036695 31:0.0065613710321485996 32:0.024283336475491524 33:-0.022283038124442101 34:-0.00083428749348968267 35:0.016746236011385918 36:0.00077113014413043857 37:0.020174669101834297 38:5.3726835176348686e-05 39:0.017781134694814682 40:0.0095463357865810394  |EV|
-1 |BT| (ROOT (S (S (NP (NP (NNP Cauda) (NNP equina) (NN syndrome)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NN cauda) (NN equina) (NN syndrome))))))))))) (VP (VBD reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (CD 1993-1997))))) (: ;) (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NN cauda) (NN equina) (NN syndrome)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997)))))) (: ;) (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine))))))) (: ;) (S (NP (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)) (CC and) (NP (CD one))))) (VP (VBD had) (NP (NP (DT a) (NN repeat) (JJ spinal) (NN anaesthetic)) (ADJP (JJ due) (PP (TO to) (NP (JJ inadequate) (NN block))))))) (: ;) (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg))))) (: ;) (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (JJ likely) (S (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NN neurotoxicity)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NN lignocaine)))))))))) (: ;) (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NN neurotoxicity)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology))))))))) (: ;) (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (JJ neurological) (NNS deficits)))) (: ;) (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NN lignocaine)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NNS concentrations))) (ADVP (RB not) (NP (QP (JJR greater) (IN than) (CD 2)) (NN %)))))))))) (CC and) (S (NP (ADVP (IN at) (NP (DT a) (JJ total) (NN dose))) (RB preferably) (RB not)) (VP (VBG exceeding) (NP (CD 60) (NN mg)))) (: ;))) |ET| |BV| 1:0.014705540612339973 2:0.017108092084527016 3:0.012121366336941719 4:0.020705288276076317 5:-0.018062273040413857 6:-0.0042962627485394478 7:0.016012204810976982 8:0.010152262635529041 9:0.015407168306410313 10:0.0042153783142566681 11:-0.012496859766542912 12:0.012068960815668106 13:-0.000694024667609483 14:0.013049256056547165 15:0.022173577919602394 16:-0.00051119003910571337 17:-0.0079763196408748627 18:-0.012158798985183239 19:-0.019536826759576797 20:0.020064596086740494 21:0.014591557517026862 22:0.013617152192940315 23:0.011663846399945518 24:0.0055554577459891634 25:-0.007820756485064825 26:-0.016835317015647888 27:0.0030276738107204437 28:0.00069436283471683658 29:-0.0046331050495306654 30:-0.0036702662085493407 31:-0.0017336808377876878 32:0.0036024406241873899 33:-0.0027646061886722841 34:0.0069731992358962698 35:-0.01508762159695228 36:0.01198609204341968 37:0.0017028081541260083 38:0.00075433465341726935 39:-0.0063108938435713453 40:-0.012405697023496032  |EV|
